Current Status of Therapeutic Strategies for Patent Ductus Arteriosus in Very- Low- Birth- Weight Infants in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jin A. | - |
dc.contributor.author | Kim, Myo-Jing | - |
dc.contributor.author | Oh, Sohee | - |
dc.contributor.author | Choi, Byung Min | - |
dc.date.accessioned | 2021-09-04T11:56:28Z | - |
dc.date.available | 2021-09-04T11:56:28Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2015-10 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/92291 | - |
dc.description.abstract | This study aimed to investigate current therapeutic strategies for patent ductus arteriosus (PDA) in very-low-birth-weight (VLBW) infants in Korea. A total of 2,254 VLBW infants among 2,386 from Korean Neonatal Network cohort born from January 2013 to June 2014 were included. No PDA was seen for 1,206 infants (53.5%) and the infants diagnosed or treated for PDA were 1,048 infants (46.5%). The proportion of infants with PDA was decreased according to the increase in gestational age (GA) and birthweight. Infants with PDA were divided into groups according to the therapeutic strategies of PDA: prophylactic treatment (PT, n= 69, 3.1%), pre-symptomatic treatment (PST, n= 212, 9.4%), symptomatic treatment (ST, n= 596, 26.4%), and conservative treatment (CT, n= 171, 7.6%). ST was the most preferred treatment modality for preterm PDA and the proportion of the patients was decreased in the order of PST, CT, and PT. Although ST was still the most favored treatment in GA< 24 weeks group, CT was more preferred than PST or ST when compared with GA >= 32 weeks group [CT vs. PST, OR 5.3, 95% CI 1.56-18.18; CT vs. ST, OR 2.9, 95% CI 1.03-8.13]. A total of 877 infants (38.9%) received pharmacological or surgical treatment about PDA, and 35.5% (801 infants) received pharmacological treatment, mostly with ibuprofen. Seventy-six infants (3.4%) received primary ligation and 8.9% (201 infants) received secondary ligation. Diverse treatment strategies are currently used for preterm PDA in Korea. Further analyses of neonatal outcomes according to the treatment strategies are necessary to obtain a standardized treatment guideline for preterm PDA. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | EXTREMELY PRETERM INFANTS | - |
dc.subject | PREMATURE-INFANTS | - |
dc.subject | TREATMENT OPTIONS | - |
dc.subject | ORAL IBUPROFEN | - |
dc.subject | RISK-FACTORS | - |
dc.subject | MANAGEMENT | - |
dc.subject | INDOMETHACIN | - |
dc.subject | OUTCOMES | - |
dc.subject | CLOSURE | - |
dc.title | Current Status of Therapeutic Strategies for Patent Ductus Arteriosus in Very- Low- Birth- Weight Infants in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Byung Min | - |
dc.identifier.doi | 10.3346/jkms.2015.30.S1.S59 | - |
dc.identifier.scopusid | 2-s2.0-84952913265 | - |
dc.identifier.wosid | 000365715000009 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.30, pp.S59 - S66 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 30 | - |
dc.citation.startPage | S59 | - |
dc.citation.endPage | S66 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | EXTREMELY PRETERM INFANTS | - |
dc.subject.keywordPlus | PREMATURE-INFANTS | - |
dc.subject.keywordPlus | TREATMENT OPTIONS | - |
dc.subject.keywordPlus | ORAL IBUPROFEN | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | INDOMETHACIN | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | CLOSURE | - |
dc.subject.keywordAuthor | Very-Low-Birth-Weight Infant | - |
dc.subject.keywordAuthor | Patent Ductus Arteriosus | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.